The Bio Report
Using Synthetic Biology to Craft One-Time, Programmable mRNA Therapeutics
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:26:30
- Mais informações
Informações:
Sinopse
The marriage of synthetic biology to mRNA is creating the potential for a range of programmable therapeutics that can provide new ways of treating deadly and chronic diseases. Strand Therapeutics is creating a platform for developing these long-acting mRNA drugs that it says can be precise, multi-functional, and deliver potentially curative treatments with a single dose. We spoke to Jake Becraft, co-founder and CEO of Strand, about the company’s programmable mRNA therapeutic platform, how it works, and the indications it is pursuing.